Skip to main content

Pluvicto Prices, Coupons and Patient Assistance Programs

Pluvicto (lutetium lu 177 vipivotide tetraxetan) is a member of the therapeutic radiopharmaceuticals drug class and is commonly used for Prostate Cancer.

The cost for Pluvicto intravenous solution (1000 MBq/mL) is around $47,939 for a supply of 1 solution, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Pluvicto is available as a brand name drug only, a generic version is not yet available. View generic Pluvicto availability for more details.

Pluvicto prices

Intravenous Solution

Quantity Per unit Price
1 $47,939.43 $47,939.43

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Pluvicto Coupons, Copay Cards and Rebates

Pluvicto offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Pluvicto Novartis Patient Support Co-pay Assistance Program

Eligible commercially insured patients may pay $25 per dose; maximum savings of $15,000 over the course of the treatment (6 infusions); for additional information contact the program at 844-638-7222.

Applies to:
Pluvicto
Number of uses:
6 times

Form more information phone: 844-638-7222 or Visit website

Patient Assistance & Copay Programs for Pluvicto

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)

Eligibility requirements:
  1. Contact program for details.
  2. Based on FPL
  3. Not specified
  4. Must be residing in the US or US territory
  5. Novartis Oncology Products: To start the application process apply to PANO (Patient Assistance Now Oncology) at www.patient.novartisoncology.com or (800) 282-7630. Kesimpta: To start the application process apply to Alongside™ Kesimpta at www.Kesimpta.com or (855) 537-4678. Leqvio: To start the application process apply to Leqvio Service Center at www.Leqvio.com or (833) 537-8462. Mayzent: To start the application process apply to Alongside™ Mayzent at www.Mayzent.com or (877) 629-9368. All medication will be shipped directly to the patient, unless otherwise noted. Please contact the program for a complete product listing. www.pap.novartis.com
Applicable drugs:
  • Pluvicto (lutetium LU 177 vipivotide tetraxetan) Injection; IV

More information please phone: 800-277-2254 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Pluvicto (lutetium LU 177 vipivotide tetraxetan) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Novartis Patient Support Program

Eligibility requirements:
  1. Contact program for details.
  2. Based on FPL
  3. FDA-approved diagnosis
  4. Must be US citizen or permanent resident residing in the US or US territories and treated by a US licensed doctor.
  5. Co-payment assistance and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Pluvicto (lutetium LU 177 vipivotide tetraxetan) Injection; IV

More information please phone: 844-638-7222 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.